Thomas Ebeling - 23 May 2024 Form 4 Insider Report for Cullinan Therapeutics, Inc. (CGEM)

Reporting relationship: Director
Issuer ticker: CGEM
Reported as of: 23 May 2024
Net transaction value: +$571,890
SEC form: 4
Accepted by SEC: 23 May 2024, 16:11:26 UTC
Prior SEC filing: 12 Jun 2023
Next SEC filing: 11 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Jacquelyn Sumer, Attorney-in-Fact

Key filing fact

Thomas Ebeling filed Form 4 for Cullinan Therapeutics, Inc. (CGEM) on 23 May 2024.

Key facts

This page summarizes Thomas Ebeling's Form 4 filing for Cullinan Therapeutics, Inc. (CGEM).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 23 May 2024, 16:11.

Change

Previous filing in this sequence was filed on 12 Jun 2023.
Current net transaction value: +$571,890.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CGEM transaction

Common Stock

Award

Transaction value: $362,163
Shares: +84,224
Change %: +125%
Price: $4.30
Shares after: 151,728
Date: 23 May 2024
Ownership: Direct

CGEM transaction

Common Stock

Award

Transaction value: $209,727
Shares: +16,475
Change %: +11%
Price: $12.73
Shares after: 168,203
Date: 23 May 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CGEM transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -84,224
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 23 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 84,224
Exercise price: $4.30
Footnotes: F1

CGEM transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -16,475
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 23 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,475
Exercise price: $12.73

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the shares vested on August 16, 2018, and the remaining shares vested in 36 equal monthly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .